ASP7663
CAS No. 1190217-35-6
ASP7663 ( —— )
Catalog No. M21597 CAS No. 1190217-35-6
ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 51 | Get Quote |
|
5MG | 77 | Get Quote |
|
10MG | 120 | Get Quote |
|
25MG | 222 | Get Quote |
|
50MG | 354 | Get Quote |
|
100MG | 514 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameASP7663
-
NoteResearch use only not for human use.
-
Brief DescriptionASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
-
DescriptionASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1190217-35-6
-
Formula Weight263.26
-
Molecular FormulaC14H14FNO3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CN1C(=O)\C(=C\C(O)=O)c2cccc(F)c12
-
Chemical Name(2E)-2-[7-Fluoro-12-dihydro-1-(2-methylpropyl)-2-oxo-3H-indol-3-ylidene]acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kojima R Nozawa K Doihara H et al. Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain[J]. European Journal of Pharmacology 2014 723:288-293.
molnova catalog
related products
-
TRPM4 inhibitor 8
TRPM4 inhibitor 8 is an inhibitor of Transient receptor potential melastatin 4(TRPM4) which contributes to viability, migration, cell cycle shift, and adhesion.
-
IA-Alkyne
IA-Alkyne is a TRP channel (TRPC) agonist. IA-Alkyne can be used to develop an isotopically tagged probe for quantitative cysteine-reactivity profiling. It also has the potential for the study of respiratory infection.
-
GSK2193874
GSK2193874 was identified as a selective orally active TRPV4 blocker.